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Langerhans cells (LC) belong to the dendritic cell lineage and 
are the principal antigen-presenting cells of squamous epi-
thelia. Short-term cultured LC (cLC) exhibit a marked aug-
mented capacity to stimulate allogeneic T cells and acquire 
the ability to activate naive T cells, probably in relation to 
enhanced expression of accessory signals. In this study, we 
evaluated the expression of B7 costimulatory molecule 
(CD80) in human freshly isolated (ftc) and cLC at both the 
protein and mRNA level. Staining of frozen skin sections did 
not reveal any epidermal dendritic cell reactive with either of 
two different anti-B7 monoclonal antibodies. ftC in suspen-
sion did not exhibit any B7 staining as evaluated by two-color 
flow-cytometry analysis and immunoelectron microscopy. 
In contrast, LC that were cultured for 24-72 h displayed 
strong surface B7 reactivity with a characteristic patchy pat-
tern. Treatment with dispase and trypsin did not reduce B7 
Epidermal Langerhans cells (LC) belong to the dendritic cell (DC) lineage and are the principal antigen-present-ing cells (APC) in squamous epithelia [1,2]. Several in vitro and in vivo studies have demonstrated that LC can potently present alloantigens, protein antigens, and hap-
tens to T lymphocytes [1-4]. Following isolation from epidermis 
and short-term culture, LC undergo profound changes in both phe-
notype and APC functions. Compared to freshly isolated cells 
(fLC), cultured LC (cLC) express higher amounts of surface major 
histocompatibility complex (MHC) class I and class II molecules, 
intercellular adhesion molecule-1 (ICAM-1), and P2 integrins [1,4]. 
Functionally, cLC exhibit a marked augmented capacity to stimu-
late allogeneic T lymphocytes and acquire the ability to activate 
naive T cells [1,5-6]. 
In addition to MHC-peptide complexes, APC need to provide 
accessory signals to activate T cells. The delivery of these costimu-
latory signals has profound consequences on T-cell-receptor en-
gagement, and the lack of costimulation may lead to functional 
inactivation of naive T cells [7]. The best characterized costimula-
tory signal is the B7 molecule (CD80) [8), which binds to CD28 or 
the CD28 homologous, CTLA-4, on T lymphocytes [9,10]. B7 
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staining of cLC. Following warming to 37°C, cLC tagged 
with anti-B7 monoclonal antibody and gold-conjugated sec-
ondary antibody could internalize surface B7 by using the 
organelles of receptor-mediated endocytosis. B7 mRNA, de-
tected by the reverse-transcriptase polymerase chain reaction 
technique, was expressed at a low level in purified (> 90% 
HLA-DR+) ftC but not in LC-depleted epidermal cells, and 
was markedly upregulated in purified cLC. The results indi-
cate that 1) fLC do not express B7 protein on their surface, 
but acquire B7 during culture, 2) surface B7 is not sensitive to 
trypsin, 3) B7 expression is regulated primarily at the mRNA 
level, and 4) membrane B7 can be internalized within cLC. 
B7 molecule on CLC may be relevant to their increased 
antigen-presenting cell potency and ability to stimulate naive 
T lymphocytes. Key words: dendritic cells/antigen presentatiollj 
accessory molecules. ] Invest Dermatol 103:54 -59, 1994 
mRNA is expressed by macrophages and B cells only after long-
term activation with interferon-y or lipopolysaccharide, respec-
tively; in contrast, it seems to be constitutively present in DC [11 J. 
Recently, cultured human peripheral blood DC, as well as human 
and mouse epidermal LC, have been shown to express functional B7 
protein, whereas freshly isolated cells did not [11-14]. In addition, 
both freshly procured and cultured crude epidermal cell (EC) sus-
pensions contained B7-specific mRNA [14), but it was unclear 
whether this mRNA was derived only from LC. 
In the present study, we investigated B7 molecule expression in 
human skin sections as well as in ftC and cLC in suspension, and 
analyzed the internalization of surface B7 in cLC. Furthermore, we 
evaluated the presence of B7 mRNA in both pl4rified ftC and cLC 
fractions. 
MATERIALS AND METHODS 
Staining of Skin Sections Frozen 4 - 6-)lm thick sections from both 
normal adult skin of the buttock and neonatal foreskin were processed for 
immunohistochemistry using a three-step avidin-biotin-peroxidase tech-
nique, as previously described [15). Primary monoclonal antibodies (MoAb) 
were anti-CDla (2.5 )lg/ml ; OKT6, Orrho Diagnostic System, Raritan, 
NJ), anti-B7 (10-50 ,ug/ml, IgG,; clone L307.4, Becton Dickinson, San 
Jose, CAl and B7-24 (10- 50 ,ug/ml, IgG2,; kindly provided by Dr. M. de 
Boer of Innogenetics, Ghent, Belgium) [16]. Control samples were incu-
bated with irrelevant matched isotype MoAb. 
EC Suspensions and LC Enrichment Skin was obtained from adult 
patients undergoing plastic surgery. Keratomized skin pieces were floated in 
0.5% dispase (Neutral protease grade II, Boehringer Mannheim, Mann· 
heim, Germany) for 60 min at 37 °C. Epidermis was then separated from 
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dermis and single EC suspensions were prepared by trypsinization (0.25% 
for 20 min at 37°C), as described [17J. EC viability was estimated by trypan 
blue exclusion to range from 85 to 97%. EC were enriched for LC as 
described [18] . Briefly, EC suspensions were allowed to adhere to collagen-
coated dishes for 90 min; the non-adherent cell fraction was then subjected 
to cold hypotonic lysis followed by density gradient centrifugation using 
Ficoll-Paque (1.077 g/ml) (Pharmacia, Uppsala, Sweden). Cells from the 
interface routinely contained 15-40% LC. 
Cell Cultures EC suspensions enriched for LC as described above were 
cultured for 24- 72 h in RPMI 1640 supplemented with heat-inactivated 
10% fetal bovine serum (FBS), 25 mM HEPES, 0.1 mM non-essential 
amino acids, 2 mM L-glutamine, 1 mM sodium pyruvate (all Biochrom KG, 
Berlin, Germany), 0.05 mM 2-mercaptoethanol (Merck, Daemstadt, Ger-
many), 100 U /ml penicillin, lOOllg/ml streptomycin, and 200 ng/ml 
human recombinant granulocyte/macrophage colony-stimulating factor 
(hrGM-CSF) (gift of Dr. G. Corbetta, Sandoz, Italy). The viability of cells 
after culture ranged from 60 to 70%. 
Raji cells (kindly provided by Dr. M. C. Re, Institute of Microbiology, 
University of Bologna, Italy) represent a Burkitt lymphoma B-celliine that 
expresses B7 mR:NA and protein [19]. Cells were cultured in RPMI 1640 
supplemented With 10% FBS, 25 mM HEPES, 2 mM L-glutamine, and 
antibiotics. 
Itnmunofluorescent Staining of Cell Suspensions Dulbecco's modi-
fied Eagle's medium supplemented with 10 mM HEPES and 1% FBS was 
used to wash cells and dilute antibodies. Freshly isolated or cultured EC 
enriched for LC were incubated with the MoAb L307.4 (1-10 Ilg/ml) or 
B7-24 (lOllg/ml) for 30 min on ice and then with phycoerythrin-cOl~u­
gated goat anti-mouse Ig (Dakopatts, Copenhagen, Denmark) for 30 min. 
After incubation with 2% normal mouse serum for 10 min, cells were stained 
with fluorescein isothiocyanate-conjugated anti-HLA-DR (0.5 ttg/106 
cells) for 30 min on ice, and finally fixed in 3% paraformaldehyde. Raji cells 
were stained with anti-B7 MoAb (both at lOllg/ml) for 30 min on ice, 
followed by phycoerythrin-conjugated goat anti-mouse Ig, and then fixed in 
3% para formaldehyde. Cells were evaluated under a Zeiss Axioscop fluores-
cent microscope and with a FACScan equipped with Lysys II software (Bec-
ton Dickinson), as previously described [20l 
Itnmunoelectron Microscopy Freshly isolated or cultured EC enriched 
for LC were incubated with anti-B7 (clone L304.7) or an irrelevant isotype-
matched MoAb and then with 5-nm gold-col~ugated goat anti-mouse IgG 
(Amersham International, Amersham, UK), as previously described [21 J. To 
study endocytosis of membrane B7, cultured EC were warmed to 37 ° C for 
5 -60 min before fixation. Cells were fixed in 1 % glutaraldehyde in a Tyr-
ode buffer, post-fixed in 1 % osmium tetroxide, dehydrated in graded alco-
hols, and finally embedded in Durcopan ACM (Flub, Buchs, Switzerland). 
Thin sections were stained with uranyl acetate and lead citrate and then 
examined with a Philips EM 400 electron microscope (Centro Interdiparti-
mentale Grandi Strumenti, Universita di Modena). Staining with an irrele-
vant primary MoAb yielded consistently negative results. 
Purification of EC Fractions fLC and cLC were separated from EC 
suspension by using an indirect immunomagnetic technique, as described in 
detail elsewhere (22). Briefly, crude EC suspensions, either freshly isolated 
or cultured for 48 h, were incubated with anti-CDla (OKT6) MoAb and 
then with Dynebeads M-450 coated with sheep anti-mouse IgGt (Dynal-
SAM) (Dynal, Oslo, Norway). The rosected cell fraction contained more 
than 90% HLA-DR+ cells (i.e., LC) as estimated by flow cytometry (22). In 
contrast, no HLA-DR+ cells could be detected in the non-rosected EC frac-
tion, corresponding to LC-depleted EC. 
Detection ofB7 mRNA Total cellular RNA was extracted from 1 X 105 
crude freshly procured EC, freshly isolated and 72-h cultured LC-depleted 
EC, purified fLC and 72-h cLC, and Raji cells using a modification of the 
guanidium isothiocyanate procedure in the presence of 10 ttg of Escherichia 
Coli tRNA [23]. To further purify the RNAs and to avoid genomic DNA 
contamination, samples were digested with RQ1, 0.05 U/ttg RNA, RNA-
sin (Promega, Madison, WI) 40 U and 10 X RQl buffer (0.4 M Tris 
pH 7.9, 0.1 M NaCI, 6 mM MgCl2, 0.1 mM CaCl2, H 20 to 200 ttl). Oli-
gonucleotide primers and probes were synthesized on an automated solid-
phase synthesizer (Applied Biosystems, Inc, Mod 381 A), as described [23J. 
The direct (nt 712-731) and reverse (nt 1177-1196) DNA primers 
for B7 define a 480-bp cON A region that spans three introns within 
the B7 gene (14J. The B7 reverse probe (ATGAGACACAT-
GAAGCTGTGGTTGGTTGTCAT A TTGAAA T) recognizes region 
931-970 (19). The reverse-transcription polymerase chain reactions (RT-
PCR) were carried out as described [23J. Briefly, total cellular RNA was 
reverse transcribed using 200 U of M-MLV reverse transcriptase (GIBCO 
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Figure 1. LC in situ do not express B7. Frozen sections from normal ap-
pearlllg skill were 1~1Cubated WIth either anti-B7 (A) or anti-CDla (B) 
MoAbs and then stamed usmg a three-step avidin-biotin-peroxidase com-
plex amplification system. Bars, 20 ttm. 
BRL, Life Technologies, Gaithersburg, MD) and Illg of OligodT 15 
primer (Boehringer) for 1 h at 37°C in 1 X cDNA buffer (10 mM Tris-
HCI, pH 8.3, 50 mM KCl, 2 mM MgCl2, 10 mM dithiothreitol and 2~0 11M dNTPs). The resulting specific cDNA fragments were am~lified 
With 2.5 U ofTaq polymerase (Promega) III the presence of 0.5 ttg primers 
and ~ X cDNA buffer. DN~ fragments correspondlllg to the different genes 
studied were generated dunng 40 cycles ofPCR (1 min at 94°C 2 min at 
55 °C, and 4 min at 72°C). Fifteen microliters of the PCR reaccio;l mixture 
(50 III total volume reaction) were separated on a 2% agarose gel and elec-
trobl?tted on~o a Gene-Screen ~embrane (NEN, Boston, MA). Blots were 
hybndlzed WIth [32P)-labeled olIgodeoxynucleotide probes as described [23]. 
For e~ch s~mple studied: the following negative controls were performed: 1) 
amphlicatlOll of genomic D~A denved from normal peripheral blood leu-
kocytes (1 ttg) or RN~ amplIficatIOn Without RT; 2) amplification without 
template. In all expenments, no amplIfied fragments due to genomic DNA 
or cDNA contamination were detected. As a control for the amount of the 
RNA used as substrate, oligomers specific for the fJ-actin cDNA (24) were 
used III parallel RT-PCR reactIOn. Each experiment was repeated at lease 
three times. 
RESULTS 
cLC, but Neither LC In Situ nor ac, Express B7 Protein 
Sections of normal human skin stained with either of the two differ-
ent M~Ab against B7 did l1~t reveal any de.ndritic epidermal positive 
cell (Fig lA). However, epIdermal dendntic cells were clearly visi-
ble when staj~ed for CD1~ antigen (Fig lB). Two-color flow-cyto-
metry analYSIS of freshly Isolated EC suspensions enriched for LC 
did not show any B7-positive LC (Fig 2A). In contrast, LC cultured 
for 72 h exhibited a marked expression ofB7 (Fig 2C), with 75-
?5% of epidermal !'lLA-DR+ cells showing B7 staining. B7 reactiv-
ity was already eVident on cLC after 24 h of culture and increased 
progressive~y during the following 2 d of culture (data not shown). 
cLC also displayed a fourfold up-regulation of surface HLA-DR 
molecules compared to ftC (Fig 2, A versus B), as previously re-
ported [5,25]. 
Immunoelectron microscopy confirmed the lack of B7 on ftC 
(data n.ot sh~wI~)an~ its presence on cLC (Fig 3A,B) . cLC exhibited 
a certam vanablhty m the number of gold particles present on their 
sur~a~e, with as few as 15 to more than 200 granules per LC. In 
a~di~lOn: B7 m?lecule on cLC surface was characterized by a patchy 
~hstnbutlOn, With aggregates of 5 - 30 gold granules mainly local-
Ized on the lo~er p~t of surfa.ce microvilli. Other freshly isolated or 
cultured EC, mcludlllg keratlllocytes and melanocytes, did not dis-
play any B7 reactivity. 
Inasmuch as other surface LC molecules, including rCAM-l, 
lymphocyte functIOn-associated antigen 3 (LFA-3), Pgp-l (CD44), 
and E-cadhenn are trypsin sensitive [2,26,27], we asked whether the 
lack of expression of B7 in ftC could be due to its removal by the 
enzymes used to disaggregate epidermal sheets. However, incuba-
tion of cLC or Raji cells with both dispase and trypsin at the same 
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concentrations and for the same time period employed to obtain 
fLC did not significantly reduce B7 staining intensity (Table I), thus 
making it very unlikely that the absence of B7 on fLC is due to 
enzyme treatment of these cells [11]. 
cLC Internalize Surface B7 by Receptor-Mediated Endo-
cytosis Immunogold-Iabeled cLC that were warmed to 37°C for 
5 - 60 min showed capping (Fig 3C) to one pole of the cell mem-
brane and internalization of gold granules. The label was progres-
sively visible in coated pits, coated vesicles, and especially in endo-
somes and vacuoles, as well as in Iysosomes (Fig 3D-F), the 
organelles that morphologically characterize receptor-mediated en-
docytosis. However, no gold particles could be observed within 
Birbeck granules, suggesting that they are not involved in the inter-
nalization process of surface B7. 
B7 mRNA Is Present in Purified fi..C and Is Upregulated in 
cLC In the next set of experiments, very highly enriched fractions 
of fLC and cLC (> 90% HLA-DR+ cells) as well as freshly isolated 
or cultured EC depleted ofLC (no HLA-DR+ cells) [22] were tested 
for the presence ofB7 mRNA by RT-PCR. The results showed that 
both purified fLC and cLC contain specific B7 mRNA [14]; how-
ever, the amount ofB7 mRNA in cLC was much higher than in fLC 
(Fig 4). In contrast, no positive signal could be detected in freshly 
procured crude EC as well as in freshly isolated and cultured LC-de-
pleted Ee. 
DISCUSSION 
Costimulatory signals playa crucial role in the activity of APC, 
influencing the outcome of peptide/MHC molecule recognition by 
T cells [7]. Abrogation of these accessory signals by chemical fixa-
tion or ultraviolet radiation may lead to clonal anergy rather than 
clonal expansion of unprimed or some activated T cells [28-30]. 
Costimulatory molecules identified on the APC surface include 
ICAM-l, LFA-3, heat-stable antigen, vascular cell adhesion mole-
cule 1 (.vCAM-l), ICAM-2, and B7 [9,31]. B7 belongs to the im-
munoglobulin superfamily of receptors and can costimulate both 
CD4+ and CD8+ T lymphocytes [32]. Binding of B7 to CD28 
results in increased interleukin 2 production by induction of cyto-
kine transcripts and stabilization of cytokine mRNA [33] . Interest-
ingly, initial activation ofT cells enhances B7 expression on APC 
via MHC class II signaling, and this, in turn, can improve the anti-
gen-presentation capacity of APC [34]. 
In the present study, we investigated the presence of B7 mRNA 
and the corresponding protein in human epidermal Le. No epider-
mal dendritic B7-positive cells could be detected in normal human 
skin sections, in agreement with data from Simon lC, et al.§ In 
contrast, Vanderberghe et al have described epidermal dendritic cells 
reactive with anti-B7 MoAb [35]. It should be noted, however, that 
in skin diseases characterized by lymphocytic infiltration (e.g., al-
lergic contact dermatitis) B7-positive epidermal LC are readily de-
tected§ (and our unpublished observations). No B7-positive cells 
were observed in freshly procured EC suspensions, whereas cLC 
showed strong B7 reactivity, as previously reported [141. Further-
more, our results indicate that the failure to detect B7 in fLc is not 
due to removal ofB7 epitopes during the preparation ofEC suspen-
sions, as enzyme treatment of either cLC or Raji cells did not reduce 
B7 staining intensity. As previously suggested with immunofluo-
rescence [14], immunoelectron microscopy confirmed that B7 pro-
tein distribution on the cLC membrane is patchy, a pattern that is 
not shared by other surface proteins such as CDla or MHC class II 
molecules. Similar patchy labeling has been described for RFDI 
MoAb, which reacts with a D locus product preferentially expressed 
on human DC [36). Using RT-PCR, we have shown that purljied 
fLC contain low levels of B7 mRNA and that, following culture, 
LC markedly upregulate B7 mRNA, indicating that B7 expression 
§ SimonJC, Dietrich A, Mielke V, Augustin M, Vanscheidt W, Ledbet-
ter JA, Linsley PS, Schopf E, Sterry W: Cutaneous expression of the B7 
activation antigen and its ligand CD28: relevance to immune responses 
generated in skin (abstr). } IrIVest Dermato/tOt :442A, t993. 
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Figure 2. cLC but not fLC express B7. Freshly isolated (A) or 72-h cui· 
tured epidermal cells enriched for LC were stained with either isotype 
matched .mouse 19 (B) or anti-B7 MoAb (L307.4) (C) and PE-conjugated 
goat antI-mouse Ig, followed by fluorescein isothiocyanate - conjugated 
anti-HLA-DR. Results are representative of three experiments. Fluores· 
cence is expressed in approximately four decades loglO scale. 
VOL. 103. NO.1 JULY 1994 EXPRESSION OF £7 ON HUMAN LANGERHANS CELLS 57 
c 
58 GIROLOMONI ET AL 
Table I. Treatment with Dispase and Trypsin Does Not 
Reduce B7 Staining on Cultured LC (cLC) or Raji Cells 
cLC 
Raji cells 
Fluorescence Intensity 
Before and After Treatment 
with Dispase and Trypsin' 
(peak channel/mean fluorescence) 
Before 
17.9/90.8 
41.1/65.5 
After 
15.9/106.9 
35.9/56.6 
• Cultured epidermal cells enriched for LC or Raji cells were treated with 0.5% 
dispase (60 min, 37°C) followed by 0.25% trypsin (20 min, 37°C). Cells were then 
stained for B7 (Raji cells) or B7 and HLA-DR (epidermal cells) and analyzed by flow 
cytometry. 
is primarily modulated at the mRNA level. B7 mRNA was exclu-
sively present in LC fractions, whereas it was not detected in LC-
depleted EC, thus confirming that LC is the only EC type express-
ing B7 under normal conditions. In contrast to Symington et al [141, 
but possibly due to the different sensitivity of the PCR technique 
used, we failed to detect B7 mRNA in freshly procured crude EC. 
Finally, our results demonstrate that when cLC are incubated at 
37 °C, membrane B7 undergoes capping and receptor-mediated en-
docytosis. This finding, although artificially induced by Ab cross-
linking, indicates that surface B7 may be subjected to spontaneous 
internalization, as hypothesized for MHC class II and CD1a mole-
cules [25,37,381. Endocytosis and recycling to the cell membrane 
could be additional mechanisms of B7 expression modulation. 
B7 upregulation in culture reflects the behavior of other surface 
molecules involved in antigen presentation, such as MHC mole-
cules, LFA-3, and ICAM-1. There is evidence that GM-CSF and 
other EC-derived cytokines are at least in part responsible for the 
phenotypic and functional changes manifested by LC and DC dur-
ing culture [1,21 . We added GM-CSF to the culture medium be-
cause it improves survival of LC in culture; however, B7 upregula-
tion was observed also in the absence of exogenous GM-CSF (not 
shown). Furthermore, in pathologic conditions,§ lymphocyte-de-
rived cytokines could be responsible for B7 expression by epidermal 
LC in vivo. In this respect, the possibility that also keratinocytes 
express B7-like molecules under certain "activation" conditions has 
been suggested [391. 
Compared to ftC, cLC exhibit an increased capacity to present 
non-self MHC antigens and to stimulate hapten-specific unprimed 
T cells [2,5,61. We hypothesize that the expression ofB7 molecule 
by cLC is relevant to these functions. As LC and DC are believed to 
be the most potent APC in the activation of naive T cells and the 
initiation of T-cell-mediated immune responses, studies on the 
regulation of accessory molecules present on these APC may greatly 
help the understanding of how T-cell immunity is generated and 
regulated. 
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Figure 4. B7 mRNA is present in fLC and is markedly upregulated in cLC. 
fLC, cLC, and LC-depleted EC were purified by an immunomagnetic tech-
nique using anti-COla MoAb. Total RNA was extracted from 1 X 10' cells 
and B7 mRNA detected by the RT -PCR amplification technique, as detailed 
under Materials alld Methods. Latle 1, freshly procured crude EC; lalle 2, 
LC-depleted freshly isolated EC; latle 3, LC-depleted cultured EC (72 h); 
lane 4, purified fLC; lane 5, purified cLC (72 h); lane 6, R;Ui cells; lane 7, 
negative control, purified genomic DNA; {atle 8, negative control. purified 
RNA without RT; latle 9, negative control. RT-PCR amplification per-
formed without RNA template. 
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